首页 | 本学科首页   官方微博 | 高级检索  
检索        


Synthesis of isotope‐labeled HSP90 inhibitor: [13CD3] and [14C]‐TAK‐459
Authors:Mihaela Plesescu  Eric L Elliott  Yuexian Li  Shimoga R Prakash
Institution:Department of Drug Metabolism and Pharmacokinetics, Isotope Chemistry Group, Millennium Pharmaceuticals Inc, Cambridge, MA, USA
Abstract:13CD3]‐TAK‐459 (1A), an HSP90 inhibitor, was synthesized from 13CD3]‐sodium methoxide in three steps in an overall yield of 29%. The key intermediate 13CD3]‐2‐methoxy‐6‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)pyridine was synthesized in two steps from 2,6‐dibromopyridine and stable isotope‐labeled sodium methoxide. 14C]‐TAK‐459 (1B) was synthesized from 14C(U)]‐guanidine hydrochloride in five steps in an overall radiochemical yield of 5.4%. The key intermediate, 14C]‐(R)‐2‐amino‐7‐(2‐bromo‐4‐fluorophenyl)‐4‐methyl‐7,8‐dihydropyrido4,3‐d]pyrimidin‐5(6H)‐one, was prepared by microwave‐assisted condensation.
Keywords:[13CD3]‐TAK‐459  [14C]‐TAK‐459  microwave chemistry  HSP90 inhibitor
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号